Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Susmitha Chandragiri

Susmitha Chandragiri

Nizam’s Institute of Medical Sciences, India

Title: Renal thrombotic micro-angiopathy associated with chemotherapy naive astrocytoma

Biography

Biography: Susmitha Chandragiri

Abstract

Cancer associated thrombotic micro-angiopathy (TMA) is a devastating event in cancer patients. Cancer associated TMA occurs either in advanced stages of cancer associated with chemotherapeutic drug use or in transplant setting. Non-chemotherapy associated TMA is mainly seen in the late stage metastasized carcinomas, predominantly adenocarcinomas, often with bone marrow infiltration. The occurrence of TMA in association with metastatic cancer portends worse prognosis. The TMA however responds to antitumor therapy. Plasma exchange, the treatment of choice for TMAs of other etiologies is of questionable benefit. No reported cases of occurrence of TMA in association with astrocytoma till date. Only chemotherapy associated TMAs in glioma following use of Bavacizumab and Aflibercept are reported. We report a case of chemotherapy naive astrocytoma presenting with TMA. There was complete resolution of TMA with normalization of serum creatinine upon surgical resection of the tumor. This emphasizes the importance of antitumor therapies in cancer associated TMAs rather than plasma exchange and immune-adsorption.